Leukotriene receptor antagonist vs placebo
Withdrawals due to adverse events · inactive EoE patients
It is very uncertain whether leukotriene receptor antagonist changes withdrawals due to adverse events at 26 weeks compared with placebo (very low certainty).
1 finding from 1 review
- RR 2.1 [0.21, 21.39]1 study · 41 participantsVery low